A short, 60 seconds read that summarises 4 handpicked articles that are worth reading about:
What are patient-reported outcomes and why are they important?
Continuing the push for innovation: Key learnings following China’s most recent NRDL update
UK: Lumykras first drug to come through ILAP and receive positive recommendation from NICE
Spain: 92% of CAR-T therapy requests approved for leukaemia patients